Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
BHF Stock Summary
Top 10 Correlated ETFs
BHF
In the News
Should You Hold Brighthouse Financial (BHF) in Your Portfolio?
Brighthouse Financial (BHF) is well-poised to gain from higher annuity and life insurance sales, a well-diversified portfolio and effective capital deployment.
Why Is Brighthouse Financial (BHF) Up 1.2% Since Last Earnings Report?
Brighthouse Financial (BHF) reported earnings 30 days ago. What's next for the stock?
Why Investors Went Dark on Brighthouse Financial Today
Investors sold out of the financial services specialist following the release of fourth-quarter results. Brighthouse badly missed analyst estimates on both the top and bottom lines.
Brighthouse (BHF) Q4 Earnings Miss, Revenues Top Estimates
Brighthouse's (BHF) fourth-quarter results reflect higher revenues offset by higher expenses.
Brighthouse Financial (BHF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Brighthouse Financial (BHF) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Brighthouse Financial (BHF) Misses Q4 Earnings Estimates
Brighthouse Financial (BHF) came out with quarterly earnings of $2.92 per share, missing the Zacks Consensus Estimate of $3.83 per share. This compares to earnings of $3.51 per share a year ago.
Brighthouse Financial (BHF) Earnings Expected to Grow: Should You Buy?
Brighthouse Financial (BHF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brighthouse Financial Announces Conference Call to Discuss Fourth Quarter and Full Year 2023 Results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) announced today that it plans to hold a conference call and audio webcast to discuss its financial results for the fourth quarter and full year ended December 31, 2023, at 8:00 a.m. Eastern Time on Tuesday, February 13, 2024. The call will follow the issuance of the Brighthouse Financial fourth quarter and full year 2023 earnings release and financial supplement on Monday, February 12, 2024, afte.
Why Investors Should Retain Brighthouse Financial (BHF) Stock
Brighthouse Financial (BHF) is well-poised to gain from the growing individual insurance market, increasing sales of life insurance products and a well-diversified and high-quality portfolio.
Brighthouse: Positioned For 2024 Capital Improvement
Brighthouse Financial shares have underperformed this past year due to capital performance and business complexity. The company reported adjusted earnings of $4.18 per share in Q3, up 3% from last year. Concerns about capital performance have weighed on the share price, but improvements are expected in 2024 given a reinsurance transaction and market movements.
BHF Financial details
BHF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 61.81 | 96.39 | 85.24 | 116.4 | 64.83 | |
Net income per share | -6.93 | -11.97 | -1.23 | 0.14 | -17.51 | |
Operating cash flow per share | 17.24 | 10.07 | 8.9 | -15.81 | -2.16 | |
Free cash flow per share | 17.24 | 10.07 | 8.9 | -15.81 | 1.75 | |
Cash per share | 716.97 | 1.02K | 1.12K | 1.11K | 123.55 | |
Book value per share | 152.53 | 204.32 | 192.66 | 75.03 | 77.84 | |
Tangible book value per share | 2.08K | 2.75K | 3.04K | 67.86 | 72.31 | |
Share holders equity per share | 152.53 | 204.32 | 192.66 | 75.03 | 77.84 | |
Interest debt per share | 42.99 | 41.06 | 39.65 | 45.48 | 112.88 | |
Market cap | 4.16B | 3.19B | 4.34B | 3.73B | 3.36B | |
Enterprise value | 5.65B | 2.52B | 3.02B | 2.77B | 2.67B | |
P/E ratio | -5.66 | -3.02 | -42.14 | 373.22 | -3.02 | |
Price to sales ratio | 0.63 | 0.38 | 0.61 | 0.44 | 0.82 | |
POCF ratio | 2.28 | 3.6 | 5.82 | -3.24 | -24.53 | |
PFCF ratio | 2.28 | 3.6 | 5.82 | -3.24 | 30.28 | |
P/B Ratio | 0.26 | 0.18 | 0.27 | 0.68 | 0.68 | |
PTB ratio | 0.26 | 0.18 | 0.27 | 0.68 | 0.68 | |
EV to sales | 0.86 | 0.3 | 0.42 | 0.33 | 0.65 | |
Enterprise value over EBITDA | -3.91 | -1.37 | -4.59 | -10.79 | -1.8 | |
EV to operating cash flow | 3.09 | 2.84 | 4.05 | -2.41 | -19.46 | |
EV to free cash flow | 3.09 | 2.84 | 4.05 | -2.41 | 24.01 | |
Earnings yield | -0.18 | -0.33 | -0.02 | 0 | -0.33 | |
Free cash flow yield | 0.44 | 0.28 | 0.17 | -0.31 | 0.03 | |
Debt to equity | 0.27 | 0.19 | 0.2 | 0.58 | 1.42 | |
Debt to assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | |
Net debt to EBITDA | -1.03 | 0.37 | 2 | 3.73 | 0.47 | |
Current ratio | 5.34K | 841.29 | 1.78K | 2.6K | 7.85 | |
Interest coverage | -7.57 | -9.98 | -4.04 | -0.16 | -9.67 | |
Income quality | -2.49 | -0.84 | -7.24 | -115.1 | 0.12 | |
Dividend Yield | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | |
Payout ratio | -0.03 | -0.04 | -0.86 | 10.4 | -0.09 | |
Sales general and administrative to revenue | 0.09 | 0.07 | 0.09 | 0.08 | 0.18 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | -1.81 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0.06 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 154.24 | 234.59 | 73 | 15.23 | 175.12 | |
ROIC | -0.05 | -0.06 | -0.02 | 0 | -0.09 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 663.55 | 952.88 | 1.07K | -1.72K | -4.13K | |
Working capital | 90.78B | 105.88B | 110.03B | 98.92B | 25.15B | |
Tangible asset value | 221.04B | 242.31B | 255.09B | 4.94B | 4.59B | |
Net current asset value | 85.08B | 100.95B | 105.87B | -121.23B | -203.38B | |
Invested capital | 0.27 | 0.19 | 0.2 | 0.58 | 1.42 | |
Average receivables | 14.24B | 15.47B | 16.13B | 17.7B | 19.55B | |
Average payables | 0 | 0 | 0 | 0 | 5.16B | |
Average inventory | -11.03B | -23.88B | -24.9B | -12.05B | -52.9B | |
Days sales outstanding | 822.95 | 693.6 | 822.5 | 831.58 | 1.75K | |
Days payables outstanding | 0 | 0 | 0 | 0 | 2.5K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | -25.62K | |
Receivables turnover | 0.44 | 0.53 | 0.44 | 0.44 | 0.21 | |
Payables turnover | 0 | 0 | 0 | 0 | 0.15 | |
Inventory turnover | 0 | 0 | 0 | 0 | -0.01 | |
ROE | -0.05 | -0.06 | -0.01 | 0 | -0.22 | |
Capex per share | 0 | 0 | 0 | 0 | 3.91 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.65 | 19.05 | 3.99 | 18.08 | 11.61 | |
Net income per share | -13.77 | -7.37 | -2.65 | 7.4 | -14.44 | |
Operating cash flow per share | -3.1 | -7.42 | -1.94 | 5.24 | 2.39 | |
Free cash flow per share | -3.1 | -7.42 | -1.94 | 20.31 | 3.15 | |
Cash per share | 1.18K | 1.23K | 1.25K | 1.24K | 123.55 | |
Book value per share | 80 | 85.37 | 74.4 | 62.89 | 77.84 | |
Tangible book value per share | 72.35 | 82.67 | 3.46K | 60.27 | 72.31 | |
Share holders equity per share | 80 | 85.37 | 74.4 | 62.89 | 77.84 | |
Interest debt per share | 46.82 | 47.4 | 48.43 | 49.38 | 50.31 | |
Market cap | 3.5B | 2.97B | 3.12B | 3.17B | 3.36B | |
Enterprise value | 2.54B | 2.45B | 2.54B | 2.48B | 2.67B | |
P/E ratio | -0.93 | -1.5 | -4.46 | 1.65 | -0.92 | |
Price to sales ratio | 7.71 | 2.32 | 11.87 | 2.71 | 4.56 | |
POCF ratio | -16.51 | -5.95 | -24.4 | 9.34 | 22.11 | |
PFCF ratio | -16.51 | -5.95 | -24.4 | 2.41 | 16.8 | |
P/B Ratio | 0.64 | 0.52 | 0.64 | 0.78 | 0.68 | |
PTB ratio | 0.64 | 0.52 | 0.64 | 0.78 | 0.68 | |
EV to sales | 5.6 | 1.9 | 9.67 | 2.12 | 3.62 | |
Enterprise value over EBITDA | -1.67 | -3.96 | -6.93 | 5.37 | -2.67K | |
EV to operating cash flow | -11.99 | -4.89 | -19.86 | 7.33 | 17.54 | |
EV to free cash flow | -11.99 | -4.89 | -19.86 | 1.89 | 13.33 | |
Earnings yield | -0.27 | -0.17 | -0.06 | 0.15 | -0.27 | |
Free cash flow yield | -0.06 | -0.17 | -0.04 | 0.41 | 0.06 | |
Debt to equity | 0.58 | 0.55 | 0.64 | 0.78 | 0.64 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 0.63 | 0.86 | 1.58 | -1.47 | 695 | |
Current ratio | 2.6K | 3.34K | 3.28K | 3.17K | 7.85 | |
Interest coverage | -32.97 | -16.18 | -9.66 | 12.18 | -0.03 | |
Income quality | -21.2 | 1.01 | 0.73 | 0.71 | -0.17 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | -0.03 | -0.05 | -0.14 | 0.05 | -0.03 | |
Sales general and administrative to revenue | 0.43 | 0.13 | 0.7 | 0.15 | 0.28 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 2.88 | 0.32 | |
Capex to revenue | 0 | 0 | 0 | 0.83 | 0.07 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.05 | 0 | 0 | 0 | 0 | |
Graham number | 157.42 | 119.01 | 66.64 | 102.35 | 159.03 | |
ROIC | -0.11 | -0.05 | -0.03 | 0.05 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -1.83K | -2.09K | 1.21K | -2.15K | -4.13K | |
Working capital | 98.92B | 100.31B | 101.66B | 98.31B | 25.15B | |
Tangible asset value | 4.94B | 5.57B | 228.15B | 3.9B | 4.59B | |
Net current asset value | -121.23B | -123.85B | 98.54B | -121.04B | -203.38B | |
Invested capital | 0.58 | 0.55 | 0.64 | 0.78 | 0.64 | |
Average receivables | 18.6B | 19.15B | 19.13B | 19.18B | 19.44B | |
Average payables | 0 | 0 | 0 | 0 | 5.16B | |
Average inventory | -13.57B | -14B | -27.59B | -27.73B | -67.04B | |
Days sales outstanding | 3.83K | 1.33K | 6.59K | 1.47K | 2.42K | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.02 | 0.07 | 0.01 | 0.06 | 0.04 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.17 | -0.09 | -0.04 | 0.12 | -0.19 | |
Capex per share | 0 | 0 | 0 | 15.07 | 0.76 |
BHF Frequently Asked Questions
What is Brighthouse Financial, Inc. stock symbol ?
Brighthouse Financial, Inc. is a US stock , located in Charlotte of Nc and trading under the symbol BHF
Is Brighthouse Financial, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $49. The lowest prediction is $49 and the highest is $49
What is BHF stock prediction ?
What is Brighthouse Financial, Inc. stock quote today ?
Brighthouse Financial, Inc. stock price is $51.73 today.
Is Brighthouse Financial, Inc. stock public?
Yes, Brighthouse Financial, Inc. is a publicly traded company.